The Home Depot is acquiring GMS Inc. in an all-cash tender offer valued at $110 per share. This blog breaks down the deal, what it means for investors, and what steps shareholders need to take now.

Klarna, the Swedish fintech giant known for its "Buy Now, Pay Later" services, is finally going public. With its IPO filing in September 2025, Klarna is making a major move onto the New York Stock Exchange under the ticker “KLAR.” Here’s a breakdown of what the IPO means, what investors should watch for, and the unique structure Klarna is bringing to Wall Street.

Legence Corp. has filed its IPO with the SEC and is eyeing a major public debut. From the Nasdaq symbol to Blackstone's majority stake, we break down all the key facts investors need to know before jumping in. LGN

Walgreens Boots Alliance has reached a turning point. Shareholders approved its $6.5 billion acquisition by Sycamore Partners, and the transaction is set to close on August 27, 2025. With the deal final, Walgreens stock will be delisted, marking the end of an era for the 120-year-old retail pharmacy giant.

Firefly Aerospace is ready for liftoff on Wall Street. Their IPO filing is packed with ambitions, risks, and market-shaking plans. Here's what you need to know about the aerospace upstart that's shooting for the stars.

Figma, the popular design collaboration platform, is taking the leap into the public market with its long-awaited IPO. With its official S-1, Figma is aiming to raise substantial capital and list under the ticker "FIG" on the NYSE. So, what does this mean for investors, tech watchers, and design enthusiasts?

Shoulder Innovations is going public, offering 5 million shares on the NYSE. Here's the scoop on pricing, business model, and what investors should expect.

Chevron has completed its high-profile $53 billion acquisition of Hess Corporation after nearly two years of negotiations, regulatory review, and shareholder involvement. This merger marks one of the largest in the oil and gas sector in recent years. Here's a full timeline of the deal, key developments, and what it all means for the future of the energy landscape.

McGraw Hill, the name synonymous with education for over a century, is stepping into a new era. With its recent IPO filing, the company is inviting the public to invest in its digital-first future. This blog unpacks the numbers, the players, and the strategy behind McGraw Hill’s move to list on the NYSE.

Med-tech innovator Carlsmed, Inc. is making its public debut with an ambitious IPO. With $100+ million potentially on the table and a Nasdaq listing in sight, here's what investors need to know about its offering, technology, financials, risks, and future growth strategy.

NIQ Global Intelligence plc has officially filed for an IPO in 2025, setting the stage for one of the most anticipated public listings of the year. Here's a detailed, plain-English breakdown of what this move means for the market and potential investors.

The tech industry is about to witness one of its most significant mergers in recent history. Synopsys, a titan in semiconductor design, is acquiring Ansys, a leader in simulation software. With a deal valued at $35 billion, this merger is set to create a powerful force at the intersection of electronics and physics.

Accelerant Holdings is set to go public. Discover key IPO facts, financials, investor insights, and how this insurance platform is positioning itself for long-term growth.

Liberty Broadband Corporation is making waves in the market with its decision to spin off GCI Liberty, Inc. This separation marks a significant milestone for both companies as they prepare to pursue more focused strategic goals. If you're an investor or just a curious onlooker, this guide will walk you through everything that’s happening, when it’s happening, and what you need to watch for.

In a bold strategic move, Novartis is acquiring Regulus Therapeutics for up to $1.8 billion. The acquisition centers around farabursen, a novel RNA-based therapy poised to disrupt treatment options for a serious kidney condition called ADPKD. Here's a deep dive into what this merger means for the future of biotech and patient care.

The New Home Company and Landsea Homes have reached a definitive merger agreement valued at approximately $1.2 billion, under which Landsea shareholders will receive $11.30 per share in cash, representing a 61 percent premium to the May 12, 2025 closing price. Backed by Apollo Global Management, this all-cash deal will create a privately held, top-25 national homebuilder with a diversified, asset-light platform spanning ten high-growth markets.

Servotronics and TransDigm have amended their merger agreement to boost the cash tender offer price to $47.00 per share following an unsolicited acquisition proposal. Here is a detailed look at the timeline, mechanics, board endorsement, and what investors should consider.

Holcim’s spin-off of its North American business into Amrize marks the birth of the continent’s preeminent building solutions firm. Learn about the transaction’s regulatory steps, financial structuring, market positioning, and what it means for investors and the construction industry.

SRM Entertainment has transformed itself into Tron Inc through a strategic reverse merger, backed by a $100 million equity infusion paid in TRX, a landmark advisory deal with TRON founder Justin Sun, and a blueprint for a TRX Treasury Strategy. In this article, we’ll explore the deal mechanics, what they mean for shareholders, and the path ahead as Tron Inc stakes its claim in the blockchain frontier.

In a landmark deal announced in May 2025, Kronos Bio, Inc. agreed to be acquired by Concentra Biosciences for $0.57 per share in cash plus one contingent value right per share. This comprehensive guide unpacks the transaction’s background, key terms, strategic drivers, and what it means for Kronos’s investors and the broader biotech mergers 2025 landscape.